Home

Daniel G Kaye

CIK 1556974 · last filed 2026-06-29

Daniel G Kaye is a corporate insider who has filed 46 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing shows the insider was granted $145.1K of CME on Jun 29, 2026. Across all open-market trades the lifetime net is +$41.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.17M

Companies

4

Total Filings

46

Lifetime Open-Market Net

$41.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CME Director 4,845 $264.78 $1.28M -$141.2K 10 2026-06-29
AB Director 48,527 $37.10 $1.80M -$196.9K 12 2026-05-22
EQH Director 60,086 $51.30 $3.08M -$178.3K 14 2026-05-21
FERRELLGAS PARTNERS L P (FGP) Delisted Director 25,000 — — $557.7K 6 2015-10-06

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 CME Grant (A) +645 $145.1K EDGAR
2026-05-22 AB Grant (A) +4,397 $170.0K EDGAR
2026-05-21 EQH Grant (A) +4,400 $185.0K EDGAR
2025-06-26 CME Grant (A) +532 $145.3K EDGAR
2025-05-23 EQH Grant (A) +3,393 $0 EDGAR
2025-05-23 CME Sell (S) −500 -$141.2K EDGAR
2025-05-23 AB Grant (A) +4,253 $170.0K EDGAR
2025-05-22 CME Notice (144) −500 -$141.2K EDGAR
2025-05-13 EQH Sell (S) −5,770 -$311.2K EDGAR
2025-05-13 AB Sell (S) −4,825 -$196.9K EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.